ACF

>>Tag: ACF

Development of a Cell-Based Assay for Determining Neutralizing Antibodies to AAV2 in Human Sera

Neutralizing Antibodies Poster Download Development of a Cell-Based Assay for Determining Neutralizing Antibodies to AAV2 in Human Sera The majority of the population [...]

Absorption Core Facility’s Increasing Presence in Boston’s Biotech Hub

ACF Bioservices, a division of Absorption Systems, recently participated in The Bioprocessing Summit in Boston to showcase our developing advancements in the Cell & Gene Therapy space. [...]

FDA approves Luxturna gene therapy for rare form of inherited vision loss

The Food and Drug Administration has approved Spark Therapeutics' Luxturna. The treatment would help those with Leber congenital amaurosis, a rare genetic retinal disease. It's specifically approved for [...]

2017-12-19T11:43:59-04:00December 19, 2017|Categories: ACF Bioservices|Tags: , , , |

FDA panel unanimously votes to approve gene therapy for blindness

Source: CNN October 12, 2017 FDA panel unanimously votes to approve gene therapy for blindness A US Food and Drug Administration advisory committee unanimously voted Thursday to approve [...]

2017-10-18T12:35:58-04:00October 18, 2017|Categories: ACF Bioservices|Tags: , , , |